Author:
Hill Simon R.,Bibby Mike C.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference14 articles.
1. Baker LH, Talley RW, Matter R, Lehane DE, Ruffnr BW, Jones SE, Morrison FS, Stephens RL, Gehan EA, Vaitkevicius VK (1976) Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU. Cancer 38: 1?7
2. Bibby MC, Loadman PM, al-Ghabban AF, Double JA (1992) Influence of hydralazine on the pharmacokinetics of tauromustine (TCNU) in mice. Br J Cancer 65: 347?350
3. Grem JL (1991) Current treatment approaches in colorectal cancer. Semin Oncol 18 [Suppl 1]: 17?26
4. Hartley-Asp B, Alenfall J (1991) Schedule dependent antagonism between tauromustine and 5-fluorouracil with or without folinic acid in the human colon cancer cell line HT-29. J Cell Pharmacol 2: 47?51
5. Hill SR, Bibby MC (1992) Sequence-dependent differences of combinations of 5-fluorouracil and tauromustine both in vitro and in vivo. Ann Oncol 3 [Suppl 1]: 109
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献